Marcus C. Schaub passed away on October 30, 2018 at the age of 82 years. He leaves behind a multifaceted and rich legacy beyond the Swiss borders and it is a great honor for us, mentees and close collaborators of his, to review once again the different stages of his career and life.
Marcus graduated from the Medical School of the University of Basel in 1961, where he also completed his doctorate in medicine (Dr. med.). Unsatisfied by—as he used to say—the empiricism of medical practice, he started his research career at the Max-Planck Institute in Munich and subsequently worked in Prof. Samuel V. Perry’s laboratory at the University of Birmingham, UK, in the then just emerging research field of muscle biochemistry, where he completed his PhD (Dr. phil. nat.). These years abroad—which he later referred to as a privilege—with his wife Nina and their three young children had a lasting impact on the young inquisitive physician eager for knowledge. Winkingly, he wrote in his epitaph for his PhD supervisor: “He (Perry) strongly held that biochemistry is closely related to gourmet cooking” and further “He was mindful of my clean and punctual qualities” (Schaub 2010b). Qualities, of course, expected from a man of Swiss origin and which ultimately paid off in his laboratory work, where meticulous accuracy was a “conditio sine qua non” for chromatography with Sephadex. From those years, Marcus’s pioneering discoveries on the regulation of muscle contraction followed (Schaub and Perry 1969, 1971; Schaub et al. 1972) and together with the discoveries from Setsuro Ebashi’s laboratory in Tokyo and John Gergely’s laboratory in Boston, they culminated in the novel consensus on troponin nomenclature at the memorable Cold Spring Harbor Symposium on Muscle Contraction in 1972 (TnI-former troponin-B, TnC-former troponin-A, and TnT). As we all know, nowadays troponins are key biomarkers of myocardial damage and form an integral and essential part of patient care in cardiology and general medicine alike. Despite the at times cumbersome laboratory work and the many frustrations inherent to research, Marcus still managed to enjoy the campus life in Birmingham, the “halcyon British way of life”, as he used to say. Even decades later, he indulged his passion of English tea ceremony with a cup of Tetley in the afternoon, when reading new publications in his office at the University of Zurich.
In 1970, Marcus had the opportunity to return to Switzerland to join the group of Prof. Peter G. Waser at the Institute of Pharmacology and Toxicology, University of Zurich, where he was appointed Professor of Pharmacology in 1980. As one of the primary lecturers in Pharmacology, he taught generations of medical and pharmacy students in his iconic, engaging, and highly didactic classes. I do very well recall his lectures on muscle contraction as if they had been yesterday. We learned, for example, why our heart, despite being exposed to rigorous workload, does not become sore as opposed to skeletal muscle. We were thrilled to understand how the arrow poison curare and succinylcholine—drugs that I am still using in my anesthetic practice—differentially affect nicotinic acetylcholine receptors at the neuromuscular junction. Not to forget his legendary review course in Pharmacology, which he organized with his colleagues Prof. Lichtensteiger and Prof. Hopf, to ease the students’ stress and to prepare them well for the looming exams. Marcus was an exceptionally gifted and passionate speaker who could fascinate his audience, students and peers alike. He was also notorious for his somewhat difficult, at times even redoubtable questions posed at poster sessions at national and international meetings, particularly among younger colleagues. However, the sole intention behind his questions was to engage specifically the younger colleagues and to foster vivid scientific discussions. When confronted years later, he disclosed that his questions were out of pure “childlike” curiosity.
His research at the Institute of Pharmacology and Toxicology was conducted in close collaboration with his good friend and colleague Prof. Hans M. Eppenberger, Head of the Institute of Cell Biology, ETH Zurich, with whom he—oddly enough—shared the same kindergarten and many years of primary and high school. He focused on contractile proteins, namely myosin heavy and light chain isoforms (Eppenberger et al. 1988; Schaub and Hirzel 1987; Schaub et al. 1984; Sutsch et al. 1992), on key structural proteins such as utrophin and dystrophin (Zuellig et al. 2000), on calcium handling in muscle contraction (Schaub et al. 2006; Schaub and Heizmann 2008), and on intracellular signaling in cardiac hypertrophy (Gosteli-Peter et al. 1996; Harder et al. 1996; Hefti et al. 1997; Schaub et al. 1998). Marcus was a skilled graphic designer and he loved the visual arts. He used to spend hours of creating figures detailing all the complex interactions among receptors, signaling pathways and calcium handling. Eliana (my wife) and myself had the privilege and pleasure to collaborate with Marcus from 2000 to 2008, first in his own laboratory (at campus Irchel) and later in our own laboratory at the University Hospital of Zurich, when we unraveled the mechanisms of volatile anesthetic-induced cardioprotection (Zaugg et al. 2002). Marcus always encouraged us to test the results from laboratory experiments in the clinical setting, something that we successfully achieved when we explored the mechanisms of volatile anesthetic-induced cardioprotection in patients undergoing coronary artery bypass graft surgery (Lucchinetti et al. 2007). Marcus was further instrumental and a great source of advice in our studies on the mitochondrial phosphoproteome (Feng et al. 2008) and the adenine nucleotide translocator-1 (Feng et al. 2010), where we took advantage of the elegant yeast model. He was a true translational scientist and an exceptional mentor, who was able to take a “humble back seat” and enjoy secretly when his mentees and trainees were in the spotlight. He was not the kind of “mentor” who just mentors to be co-authored, a type of “mentorship” unfortunately far too common.
With two important legacies, one for Swiss heart research and one for European muscle research, Marcus leaves behind two veritable “pearls”. Together with three other colleagues, Marcus founded the “International Workshop on Cardiomyocyte Biology”. This workshop took place for the first time in 1994 and since then every three years at the congress center Monte Verità in Ascona (http://www.cardioascona.ch/). For many years, he was one of the main organizers and even up to recently, as member of the Scientific Board, he made sure that the most interesting and hottest topics were tabled in the program and that the best world-renowned researchers were invited for keynote lectures, providing an outstanding educational experience for all participants (Linke and Schaub 2013; Schaub and Abriel 2016; Schaub and Kleber 2010). The second legacy was clearly inspired by the “Golden days of British muscle Biochemistry”. Marcus founded the “European Society of Muscle Research (ESMR)” in 1971, where he served more than 25 years as chairman. Initially,—Marcus amused to tell—ESMR had the dubious name European Muscle Club suggestive of a body building club rather than a thought-minded research society. Marcus narrates in one of his excellent articles about the birth and evolution of ESMR (Schaub 2008, 2010a), which I can highly recommend as further reading, that there was indeed a breathtaking body building performance at the memorable 1985 congress in Ulm, Germany. Eventually, bodybuilding is only a kind of applied myology, right?
Marcus had an extremely broad and profound knowledge in science and medicine, but he was at the same time interested in many other things including theater, fine arts, economics and sociopolitical topics. After his frequent visits to Zurich’s arts galleries, he used to invite all his colleagues to the famous Café Odeon, a world-renowned cozy meeting place for all sorts of intellectuals and artists, to continue his vivid discussions. Marcus and his wife Nina loved to invite friends for dinner. These stimulating nights were flavored with Marcus’s highly entertaining anecdotes. Probably not many people know that Marcus himself was a painter, occasionally giving away one of his paintings to very close friends.
I liked Marcus’s presentations most where he amalgamated science and arts and transformed the resulting findings and intuition back into the reality of the human society. From these presentations and the many discussions on all contrivable topics we had together, I am certain that he did not like the idea of the “Selfish Gene” by Richard Dawkins (Dawkins 1976), but that he strongly advocated for the perception of life as a sort of music created by the complex interaction between all the diverse biomolecules [“Music of Life” by Denis Noble (Noble 2006)]. The allusion in my title of this obituary to Stephen Hawking’s famous book “A brief history of time” (Hawking 1988) is intentional, as both men, Stephen and Marcus, shared the same unconditional passion for science (Fig. 1).
I would like to close with Marcus’s own words taken from his ingenious essay where he describes “Ambiguity in the heart, art, and science” (Schaub 2013):
This brings us back to science, where a lot more is required to design inventive new hypothesis-driven research, including such qualities as imagination, innovation, unconventional approaches, inspiration and exchange of ideas between the young and the more experienced elders, enthusiasm, fervor and, above all, a warm heart.
References
Dawkins R (1976) The selfish gene. Oxford University Press, Inc., New York
Eppenberger ME, Hauser I, Baechi T, Schaub MC, Brunner UT, Dechesne CA, Eppenberger HM (1988) Immunocytochemical analysis of the regeneration of myofibrils in long-term cultures of adult cardiomyocytes of the rat. Dev Biol 130:1–15
Feng J, Zhu M, Schaub MC, Gehrig P, Roschitzki B, Lucchinetti E, Zaugg M (2008) Phosphoproteome analysis of isoflurane-protected heart mitochondria: phosphorylation of adenine nucleotide translocator-1 on Tyr194 regulates mitochondrial function. Cardiovasc Res 80:20–29
Feng J, Lucchinetti E, Enkavi G et al (2010) Tyrosine phosphorylation by Src within the cavity of the adenine nucleotide translocase 1 regulates ADP/ATP exchange in mitochondria. Am J Physiol Cell Physiol 298:C740–C748
Gosteli-Peter MA, Harder BA, Eppenberger HM, Zapf J, Schaub MC (1996) Triiodothyronine induces over-expression of alpha-smooth muscle actin, restricts myofibrillar expansion and is permissive for the action of basic fibroblast growth factor and insulin-like growth factor I in adult rat cardiomyocytes. J Clin Invest 98:1737–1744
Harder BA, Schaub MC, Eppenberger HM, Eppenberger-Eberhardt M (1996) Influence of fibroblast growth factor (bFGF) and insulin-like growth factor (IGF-I) on cytoskeletal and contractile structures and on atrial natriuretic factor (ANF) expression in adult rat ventricular cardiomyocytes in culture. J Mol Cell Cardiol 28:19–31
Hawking S (1988) A brief history of time. Bantam Dell Publishing Group, New York
Hefti MA, Harder BA, Eppenberger HM, Schaub MC (1997) Signaling pathways in cardiac myocyte hypertrophy. J Mol Cell Cardiol 29:2873–2892
Linke WA, Schaub MC (2013) 7th Ascona International Workshop on Cardiomyocyte Biology: cardiac pathways of differentiation, metabolism and contraction. Biochim Biophys Acta 1833:781–782
Lucchinetti E, Hofer C, Bestmann L et al (2007) Gene regulatory control of myocardial energy metabolism predicts postoperative cardiac function in patients undergoing off-pump coronary artery bypass graft surgery: inhalational versus intravenous anesthetics. Anesthesiology 106:444–457
Noble D (2006) The music of life: biology beyound genes. Oxford University Press, Inc., New York
Schaub MC (2008) Footsteps of the European society for muscle research (1971–2008). J Muscle Res Cell Motil 29:151–154
Schaub MC (2010a) Forty years of European society for muscle research. Eur J Transl Myol Myol Rev 1:77–82
Schaub MC (2010b) Golden days of British muscle biochemistry: In memoriam S. V. Perry. J Muscle Res Cell Motil 31:9–11
Schaub MC (2013) Ambiguity in the heart, art and science by Marcus C. Schaub. Biochim Biophys Acta 1833:954–955
Schaub MC, Abriel H (2016) 8th Ascona International Workshop on Cardiomyocyte Biology, 3–7 May, 2015 Integration of Developmental and Environmental Cues in the Heart Congressi Stefano Franscini, Monte Verita, Ascona, Switzerland. Biochim Biophys Acta 1863:1691–1695
Schaub MC, Heizmann CW (2008) Calcium, troponin, calmodulin, S100 proteins: from myocardial basics to new therapeutic strategies. Biochem Biophys Res Commun 369:247–264
Schaub MC, Hirzel HO (1987) Atrial and ventricular isomyosin composition in patients with different forms of cardiac hypertrophy. Basic Res Cardiol 82(Suppl 2):357–367
Schaub MC, Kleber AG (2010) Ascona Workshop on Cardiomyocyte Biology: highlights from the Sixth International Workshop. J Cardiovasc Pharmacol 56:1–5
Schaub MC, Perry SV (1969) The relaxing protein system of striated muscle. Resolution of the troponin complex into inhibitory and calcium ion-sensitizing factors and their relationship to tropomyosin. Biochem J 115:993–1004
Schaub MC, Perry SV (1971) The regulatory proteins of the myofibril. Characterization and properties of the inhibitory factor (troponin B). Biochem J 123:367–377
Schaub MC, Perry SV, Hacker W (1972) The regulatory proteins of the myofibril. Characterization and biological activity of the calcium-sensitizing factor (troponin A). Biochem J 126:237–249
Schaub MC, Tuchschmid CR, Srihari T, Hirzel HO (1984) Myosin isoenzymes in human hypertrophic hearts—shift in atrial myosin heavy-chains and in ventricular myosin light-chains. Eur Heart J 5:85–93
Schaub MC, Hefti MA, Zuellig RA, Morano I (1998) Modulation of contractility in human cardiac hypertrophy by myosin essential light chain isoforms. Cardiovasc Res 37:381–404
Schaub MC, Hefti MA, Zaugg M (2006) Integration of calcium with the signaling network in cardiac myocytes. J Mol Cell Cardiol 41:183–214
Sutsch G, Brunner UT, von Schulthess C, Hirzel HO, Hess OM, Turina M, Krayenbuehl HP, Schaub MC (1992) Hemodynamic performance and myosin light chain-1 expression of the hypertrophied left ventricle in aortic valve disease before and after valve replacement. Circ Res 70:1035–1043
Zaugg M, Lucchinetti E, Spahn DR, Pasch T, Schaub MC (2002) Volatile anesthetics mimic cardiac preconditioning by priming the activation of mitochondrial K(ATP) channels via multiple signaling pathways. Anesthesiology 97:4–14
Zuellig RA, Bornhauser BC, Knuesel I, Heller F, Fritschy JM, Schaub MC (2000) Identification and characterisation of transcript and protein of a new short N-terminal utrophin isoform. J Cell Biochem 77:418–431
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Zaugg, M., Lucchinetti, E. A brief history of M. C. Schaub’s legacies: a life dedicated to heart and muscle research. J Muscle Res Cell Motil 39, 61–63 (2018). https://doi.org/10.1007/s10974-019-09502-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10974-019-09502-4